ID
20952
Beschrijving
This study is a prospective, interventional, open-label, multi-center early access program for the use of Ra-223 Cl2 in HRPC/CRPC (Hormone refractory prostate cancer / Castrate resistant prostate cancer) patients diagnosed with bone metastasis and to collect additional short and long term safety data on the product. NCT01618370
Trefwoorden
Versies (1)
- 30-03-17 30-03-17 -
Geüploaded op
30 maart 2017
DOI
Voor een aanvraag inloggen.
Licentie
Creative Commons BY-NC 3.0
Model Commentaren :
Hier kunt u commentaar leveren op het model. U kunt de tekstballonnen bij de itemgroepen en items gebruiken om er specifiek commentaar op te geven.
Itemgroep Commentaren voor :
Item Commentaren voor :
U moet ingelogd zijn om formulieren te downloaden. AUB inloggen of schrijf u gratis in.
Radium-223 Dichloride (Alpharadin) DRKS00006460 NCT01618370 in Castration-Resistant (Hormone-Refractory) Prostate Cancer Patients With Bone Metastases (Survival Follow-up)
Radium 223 Dichloride (Alpharadin) - Survival Follow-up
- StudyEvent: ODM
Beschrijving
End of Survival Follow-up
Beschrijving
Primary reason for discontinuation
Datatype
text
Alias
- UMLS CUI [1,1]
- C0008976
- UMLS CUI [1,2]
- C0457454
- UMLS CUI [1,3]
- C1549995
Beschrijving
If primary reason is `Other`,specify
Datatype
text
Alias
- UMLS CUI [1,1]
- C1549995
- UMLS CUI [1,2]
- C0205394
Beschrijving
dd MMM Y.Y.Y.Y
Datatype
date
Alias
- UMLS CUI [1,1]
- C1549995
- UMLS CUI [1,2]
- C1148348
Beschrijving
Primary cause of death
Datatype
text
Alias
- UMLS CUI [1]
- C0007465
Beschrijving
Other Cause of Death
Datatype
text
Alias
- UMLS CUI [1]
- C0007465
Similar models
Radium 223 Dichloride (Alpharadin) - Survival Follow-up
- StudyEvent: ODM
C0220825 (UMLS CUI [1,2])
C0457454 (UMLS CUI [1,2])
C1549995 (UMLS CUI [1,3])
C0205394 (UMLS CUI [1,2])
C1148348 (UMLS CUI [1,2])